spot_img
Thursday, December 1, 2022
HomeHealthcareModerna and Merck collaborate to develop mRNA vaccine against melanoma

Moderna and Merck collaborate to develop mRNA vaccine against melanoma

-

- Advertisement -

Merck to pay $250 million to Moderna

American pharmaceutical companies Moderna and Merck announced today an agreement to co-develop and commercialize an mRNA vaccine, currently being tested in combination with a cancer drug, to treat melanoma.

- Advertisement -

Moderna and Merck (or MSD outside North America) have been collaborating since 2016 on vaccine development against cancer.

Merck to pay $250 million to Moderna to activate the option envisaged at the beginning of their collaboration and to proceed to the next stage and – if everything develops according to expectations – to make the preparation available on the market.

- Advertisement -

After the deal was announced, Moderna’s stock jumped 11% in mid-day trading in New York.

Moderna, one of the first companies to develop an mRNA vaccine against Covid-19, believes that this technique can also be used for treatments against influenza, HIV, autoimmune diseases, cardiovascular diseases and many forms of cancer.

Results from phase 2 trials of the mRNA vaccine in combination with Keytruda to treat melanoma are expected by the end of the year.

- Advertisement -
spot_img
Philip
Philip
I am a highly experienced and successful news journalist, with many years of experience in the industry. I have worked for some of the biggest news organisations in the world, and have gained a huge amount of knowledge and expertise in the field. I am now working as an author at News Bulletin 247, where I mostly cover sports news. I am a highly skilled writer and reporter, with a keen eye for detail and a passion for finding stories that others might miss. I am always looking for new and interesting ways to tell stories, and my work is always of the highest quality. I am also a very experienced editor, with a good understanding of how to make stories flow well and be easy to read.

Related articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

1,250FansLike
1,500FollowersFollow

Latest posts